Can Fite Biopharma Ltd (CANF) Price Prediction & ForecastCANFCan Fite Biopharma Ltd

Alphio's CANF stock price prediction model matches the current Can Fite Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.63 (+0.37%). The 1-week path is $1.55 (-4.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Can Fite Biopharma Ltd (CANF) is not a good buy. The stock is trading at $1.62, significantly down from its 52-week high of $12.30, which reflects a staggering 80.18% decline over the past year. The RSI is at 34.499, indicating that the stock is oversold, but the forward P/E ratio is 2.9665, suggesting that the stock may still be undervalued. However, the company continues to report substantial net losses, with a net income of -2,300,500 USD in Q2 2026. The main risk is the ongoing operating losses and the negative sentiment reflected in the 20-day change of -14.74%.

Can Fite Biopharma Ltd (CANF) last closed at $1.62, gaining +1.25%. These facts feed the 1-day and 1-week CANF price prediction above.